The University of Cologne is a university in Cologne, Germany. It was established in the year 1388 and is one of the most prestigious and research intensive universities in Germany. It was the sixth university to be established in Central Europe. It closed in 1798 before being re-established in 1919.

During the past decade, Universitat zu Koln conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 6 clinical trials were completed, i.e. on average, 120% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Universitat zu Koln" #1 sponsor was "Celgene" with 4 trials, followed by "Abbott" with 2 trials sponsored, "Astellas Pharma Inc" with 2 trials sponsored, "Gilead Sciences" with 2 trials sponsored and "Actelion" with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universitat zu Koln" #1 collaborator was "Basilea Pharmaceutica International Ltd" with 2 trials as a collaborator and "Digna Biotech S.L." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Universitat zu Koln" are "HIV Infections" (3 trials), "Aspergillosis" (2 trials), "HIV-1 Infection" (2 trials), "Lymphoma, Non-Hodgkin" (2 trials) and "Melanoma" (2 trials). Many other conditions were trialed in "Universitat zu Koln" in a lesser frequency.

Most popular intervention types in "Universitat zu Koln" are "Drug" (14 trials), "Procedure" (2 trials), "Device" (1 trials), "Genetic" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "FTC/RPV/TAF" (2 trials), "FTC/RPV/TAF Placebo" (2 trials), "JCAR017" (2 trials), "Lopinavir/Ritonavir" (2 trials) and "Placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Universitat zu Koln" are 17 trials for "All" genders.

Currently, there are NaN active trials in "Universitat zu Koln". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Universitat zu Koln, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Universitat zu Koln, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".

Universitat zu Koln has several departments that took part in Clinical trials: "1st Dept. of Medicine, Cologne University Hospital" - 26 trials, "University of Cologne, Dept. of Psychiatry and Psychotherapy" - 3 trials, "Dpt. of Dermatology, University of Cologne" - 2 trials